A New Regimen: Africa's AIDS Experts Turn to Antibiotics to Slow the Epidemic CDC Daily UpdateImportant note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Click here to return to CDC Daily Update main menu





DonateNow




A New Regimen: Africa's AIDS Experts Turn to Antibiotics to Slow the Epidemic

Wall Street Journal (12/27/97) P. A1
Bennett, Amanda


Abstract: In Africa, where the promising protease inhibitor combinations are far out of reach, health workers are putting new faith in a stalwart medicine--the antibiotic. Scientists have found that by using antibiotics to limit the proliferation of conventional sexually transmitted bacterial diseases, they can dramatically reduce the spread of HIV. Initial studies that reduced new HIV infections in specific regions around Lake Victoria by as much as 40 percent have inspired the U.S. Agency for International Development and the World Bank to spend some $16 million in efforts to expand the antibiotic treatments throughout Tanzania and Uganda. While experts believe the program could ultimately save thousands of lives, there are significant hurdles, including doubts about whether similar success rates can be achieved on a broader scale, the prohibitive cost of even-conventional medicines in Africa, and concerns regarding widespread antibiotic distribution and resistant strains of diseases.


961227
AD962445


Copyright © 1996 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.

.